Laura Towart

Laura Towart founded Vivan Therapeutics to advance a groundbreaking personalized approach to cancer developed at Mt Sinai Medical Center. Laura became passionate about personalized medicine during her PhD studies at Weill Cornell Graduate School for Medical Sciences/Memorial Sloan Kettering Cancer Center. Since then she has been actively involved in translational advances in medicine. In 2008 she co-founded Celmatix, and was the founding CEO, and helped build a next-generation women’s health company leveraging big-data and genomics. Laura is an avid startup and technology strategist and angel investor, with a focus on personalized medicine. Laura created the My Personal Therapeutics Foundation to provide financial support to patients who would like to access personalized cancer care but who cannot afford it. Laura is driven to help develop and foster biotechnology communities globally, and is an active advisor, speaker and mentor.